  | Severino, M., Peretti, D. E., Bardiau, M., Cavaliere, C., Doyen, M., Gonzalez-Escamilla, G., Horowitz, T., Nørgaard, M., Perez, J. A. M., Perovnik, M., Rullmann, M., Steenken, D., Talmasov, D., Tang, C., Volpi, T., Xu, Z., Bertoldo, A., Calhoun, V. D., Caminiti, S. P., ... Veronese, M. (2025). Molecular connectivity studies in neurotransmission: a scoping review. Imaging Neuroscience, 3. doi:10.1162/imag_a_00530  Peer Reviewed verified by ORBi |
  | Sala, A., Gosseries, O., Laureys, S., & Annen, J. (2025). Advances in neuroimaging in disorders of consciousness. In Handbook of Clinical Neurology: Coma, Stupor, and Related Disorders of Consciousness. Elsevier. doi:10.1016/B978-0-443-13408-1.00008-7 Editorial reviewed |
 | Sanz, L., Lejeune, N., Szymkowicz, E., Bonin, E., Panda, R., Sala, A., Thibaut, A., Huerta-Gutierrez, R., Dardenne, N., Dikenstein, D., Van Goethem, S., Ledoux, D., Hustinx, R., Stender, J., Farber, N. M., Zafonte, R. D., Schiff, N. D., Laureys, S., & Gosseries, O. (December 2024). Apomorphine for prolonged disorders of consciousness: a multimodal open-label study. EClinicalMedicine, 78, 102925. doi:10.1016/j.eclinm.2024.102925 Peer Reviewed verified by ORBi |
 | Rogeau, A., Boer, A. J., Guedj, E., Sala, A., Sommer, I. E., Veronese, M., van der Weijden-Germann, M., EANM Neuroimaging Committee, & Fraioli, F. (2024). EANM perspective on clinical PET and SPECT imaging in schizophrenia-spectrum disorders: a systematic review of longitudinal studies. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-024-06987-1 Peer Reviewed verified by ORBi |
 | Mastenbroek, S. E.* , Sala, A.* , Vállez García, D., Shekari, M., Salvadó, G., Lorenzini, L., Pieperhoff, L., Wink, A. M., Lopes Alves, I., Wolz, R., Ritchie, C., Boada, M., Visser, P. J., Bucci, M., Farrar, G., Hansson, O., Nordberg, A. K., Ossenkoppele, R., Barkhof, F., ... Alzheimer's Disease Neuroimaging Initiative on behalf of the AMYPAD consortium. (09 July 2024). Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity. Neurology, 103 (1), 209419. doi:10.1212/WNL.0000000000209419 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Cecconi, B., van der Lande, G., & Sala, A. (2024). Neural Correlates of Consciousness. In Coma and Disorders of Consciousness. Springer International Publishing. doi:10.1007/978-3-031-50563-8_1 Editorial reviewed |
 | Lizarraga, A., Ripp, I., Sala, A., Shi, K., Düring, M., Koch, K., & Yakushev, I. (2024). Similarity between structural and proxy estimates of brain connectivity. Journal of Cerebral Blood Flow and Metabolism, 271678X231204769. doi:10.1177/0271678X231204769 Peer Reviewed verified by ORBi |
 | Imarisio, A., Pilotto, A., Premi, E., Caminiti, S. P., Presotto, L., Sala, A., Zatti, C., Lupini, A., Turrone, R., Paghera, B., Borroni, B., Perani, D., & Padovani, A. (October 2023). Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease. Parkinsonism and Related Disorders, 115, 105848. doi:10.1016/j.parkreldis.2023.105848 Peer Reviewed verified by ORBi |
 | Annen, J., Frasso, G., van der Lande, G., Bonin, E., Vitello, M., Panda, R., Sala, A., Cavaliere, C., Raimondo, F., Bahri, M. A., Schiff, N. D., Gosseries, O., Thibaut, A., & Laureys, S. (26 July 2023). Cerebral electrometabolic coupling in disordered and normal states of consciousness. Cell Reports, 42 (8), 112854. doi:10.1016/j.celrep.2023.112854 Peer Reviewed verified by ORBi |
Meys, M., Danuta, S., Wang, Z., Abagnale, S., Kaan, B., Alnagger, N., Bardiau, M., Kói, T., Beaudart, C., Laureys, S., Gosseries, O., Thibaut, A., Sala, A., & Annen, J. (23 June 2023). Disorders of Consciousness through Global Neurophysiological Measures: a Meta-Analysis [Paper presentation]. 26th Annual Meeting of the Association for the Scientific Study of Consciousness, New York, United States. |
 | Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., Ledoux, D., Hustinx, R., Laureys, S., & Gosseries, O. (01 April 2023). Multimodal open-label study of apomorphine in disorders of consciousness [Paper presentation]. 14th Biennial World Congress on Brain Injury, Dublin, Ireland. Peer reviewed* These authors have contributed equally to this work. |
 | Sala, A., Lizarraga, A., Caminiti, S. P., Calhoun, V. D., Eickhoff, S. B., Habeck, C., Jamadar, S. D., Perani, D., Pereira, J. B., Veronese, M., & Yakushev, I. (2023). Brain connectomics: time for a molecular imaging perspective? Trends in Cognitive Sciences. doi:10.1016/j.tics.2022.11.015 Peer Reviewed verified by ORBi |
 | Meys, M., Wang, Z., Abagnale, S., Kaan, B. O., Alnagger, N., Bardiau, M., Beaudart, C., Laureys, S., Gosseries, O., Thibaut, A., Sala, A., & Annen, J. (2023). Global Neurophysiological Measures in Disorders of Consciousness: a MetaAnalysis. European Journal of Neurology, Supplement 1, 120-87. Editorial reviewed |
 | Lizarraga, A., Sala, A., Ripp, I., Koch, K., & Yakushev, I. (2023). Test-retest reproducibility of common estimates of brain connectivity [Paper presentation]. Resting State Brain Connectivity Conference. |
 | Sala, A., Kaan, B., Alnagger, N., Abagnale, S., Meys, M., Wang, Z., Bardiau, M., Eickhoff, S., Tettamanti, M., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2023). Brain alterations in disorders of consciousness: a coordinate-based metaanalysis. European Journal of Neurology, 30 (Supplement 1), 120-187. Editorial reviewed |
 | Sala, A., Herfert, K., Gonzalez-Escamilla, G., Caminiti, S. P., & Bertoglio, D. (2023). Editorial: Imaging brain molecular connectivity in health and disease. Frontiers in Human Neuroscience, 17, 1298382. doi:10.3389/fnhum.2023.1298382 Peer Reviewed verified by ORBi |
Sala, A., Kaan, B. O., Alnagger, N., Abagnale, S., Meys, M., Wang, Z., Bardiau, M., Eickhoff, S., Tettamanti, M., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2023). A coordinate-based meta-analysis of brain alterations in disorders of consciousness [Paper presentation]. OHBM. |
Sala, A., Kaan, B. O., Alnagger, N., Abagnale, S., Meys, M., Wang, Z., Bardiau, M., Eickhoff, S., Tettamanti, M., Laureys, S., Gosseries, O., Thibaut, A., & Annen, J. (2023). Neural correlates of consciousness: a coordinate-based meta-analysis of brain alterations in disorders of consciousness [Paper presentation]. 26th Annual Meeting of the Association for the Scientific Study of Consciousness. |
Leandro, S., Selte, A., Andris, C., Thibaut, A., Bonin, E., Larroque, S., Bernard, C., Hustinx, R., Laureys, S., Sala, A., & Gosseries, O. (2023). Visual deficits and occipital metabolism correlate with levels of consciousness in severe brain injury [Paper presentation]. World Congress on Brain Injury, Ireland. |
 | Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., Ledoux, D., Hustinx, R., Laureys, S., & Gosseries, O. (06 September 2022). Apomorphine dopaminergic neuromodulation in severe brain- injured patients with consciousness disorders – a pilot study [Paper presentation]. GIGA day 2022, Liège, Belgium. * These authors have contributed equally to this work. |
 | Cacciaglia, R., Salvadó, G., Molinuevo, J. L., Shekari, M., Falcon, C., Operto, G., Suárez-Calvet, M., Milà-Alomà, M., Sala, A., Rodriguez-Vieitez, E., Kollmorgen, G., Suridjan, I., Blennow, K., Zetterberg, H., Gispert, J. D., Alzheimer’s Disease Neuroimaging Initiative, & ALFA study. (April 2022). Age, sex and APOE-ε4 modify the balance between soluble and fibrillar β-amyloid in non-demented individuals: topographical patterns across two independent cohorts. Molecular Psychiatry, 27 (4), 2010 - 2018. doi:10.1038/s41380-022-01436-7 Peer Reviewed verified by ORBi |
 | Sala, A. (2022). Lifelong bilingualism and mechanisms of neuroprotection in Alzheimer dementia. Human Brain Mapping. doi:10.1002/hbm.25605 Peer Reviewed verified by ORBi |
 | Sala, A., Lizarraga, A., Ripp, I., Cumming, P., & Yakushev, I. (2022). Static versus Functional PET: Making Sense of Metabolic Connectivity. Cerebral Cortex. doi:10.1093/cercor/bhab271 Peer Reviewed verified by ORBi |
 | Sala, A. (2022). An automated FDG-PET pipeline for the analysis of glucose brain metabolism in disorders of consciousness. Journal of Cerebral Blood Flow and Metabolism, 42 (1 suppl), 108 - 273. doi:10.1177/0271678X221096357 Peer Reviewed verified by ORBi |
 | Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., LEDOUX, D., HUSTINX, R., LAUREYS, S., & Gosseries, O. (2022). Investigation of apomorphine-related neural mechanisms in severe brain-injured patients with prolonged disorders of consciousness [Paper presentation]. 25th annual meeting of the ASSC, Amsterdam, Netherlands. Editorial reviewed* These authors have contributed equally to this work. |
 | Sanz, L., Lejeune, N., Bonin, E., Panda, R., Sala, A., Dikenstein, D., Farber, N., Thibaut, A., Laureys, S., & Gosseries, O. (29 July 2021). Increased brain metabolism and EEG connectivity after apomorphine therapy in patients with chronic disorders of consciousness [Poster presentation]. the 2021 Virtual World Congress on Brain Injury. Peer reviewed |
 | Sanz, L., Lejeune, N., Bonin, E., Panda, R., Sala, A., Dikenstein, D., Farber, N., Thibaut, A., Laureys, S., & Gosseries, O. (01 June 2021). Apomorphine therapy for patients with disorders of consciousness: a multimodal open-label study [Paper presentation]. 7th Congress of the European Academy of Neurology. Peer reviewed |
 | Sala, A. (2021). In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases. Alzheimer's Research and Therapy. doi:10.1186/s13195-021-00925-1 Peer Reviewed verified by ORBi |
 | Caminiti, S. P., Sala, A., Presotto, L., Chincarini, A., Sestini, S., Perani, D., Schillaci, O., Berti, V., Calcagni, M. L., Cistaro, A., Morbelli, S., Nobili, F., Pappatà, S., Volterrani, D., & Gobbo, C. L. (2021). Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-020-05175-1 Peer Reviewed verified by ORBi |
 | Sala, A., Kaan Ok, B., Thibaut, A., Gosseries, O., LAUREYS, S., & Annen, J. (2021). A meta-analysis of brain glucose hypo-metabolism in patients with disorders of consciousness. European Journal of Nuclear Medicine and Molecular Imaging. Peer Reviewed verified by ORBi |
 | Sala, A., Annen, J., Thibaut, A., & LAUREYS, S. (2021). Disturbance of brain glucose metabolism in disorders of consciousness: a meta-analysis. Journal of Nuclear Medicine. Peer Reviewed verified by ORBi |
Annen, J., Sala, A., Bonin, E., Sanz, L., Barra, A., Cecconi, B., Vitello, M., Szymkowicz, E., Cardone, P., BERNARD, C., Martial, C., LAUREYS, S., Gosseries, O., & Thibaut, A. (2021). FDG-PET/CT data of healthy volunteers and patients with disorders of consciousness. doi:10.25493/7TXP-WCF  Dataset: 10.25493/7TXP-WCF |
 | Sala, A., Caprioglio, C., Santangelo, R., Vanoli, E. G., Iannaccone, S., Magnani, G., & Perani, D. (2020). Brain metabolic signatures across the Alzheimer's disease spectrum. European Journal of Nuclear Medicine and Molecular Imaging, 47 (2), 256-269. doi:10.1007/s00259-019-04559-2 Peer Reviewed verified by ORBi |
 | Catricalà, E., Polito, C., Presotto, L., Esposito, V., Sala, A., Conca, F., Gasparri, C., Berti, V., Filippi, M., Pupi, A., Sorbi, S., Iannaccone, S., Magnani, G., Cappa, S. F., & Perani, D. (2020). Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study. Neurology. doi:10.1212/WNL.0000000000010967 Peer Reviewed verified by ORBi |
 | Sala, A., Nordberg, A., & Rodriguez-Vieitez, E. (2020). Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity. Molecular Psychiatry. doi:10.1038/s41380-020-00950-w Peer Reviewed verified by ORBi |
 | Iaccarino, L.* , Sala, A.* , Caminiti, S. P., Presotto, L., & Perani, D. (2020). In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease. Journal of Alzheimer's Disease, 75 (3), 1003-1016. doi:10.3233/JAD-190954 Peer reviewed* These authors have contributed equally to this work. |
 | Perini, G., Rodriguez-Vieitez, E., Kadir, A., Sala, A., Savitcheva, I., & Nordberg, A. (2020). Clinical impact of (18)F-FDG-PET among memory clinic patients with uncertain diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-020-04969-7 Peer Reviewed verified by ORBi |
 | Santangelo, R., Masserini, F., Agosta, F., Sala, A., Caminiti, S. P., Cecchetti, G., Caso, F., Martinelli, V., Pinto, P., Passerini, G., Perani, D., Magnani, G., & Filippi, M. (2020). CSF p-tau/Aβ(42) ratio and brain FDG-PET may reliably detect MCI "imminent" converters to AD. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-020-04853-4 Peer Reviewed verified by ORBi |
 | Carli, G., Caminiti, S. P., Sala, A., Galbiati, A., Pilotto, A., Ferini-Strambi, L., Padovani, A., & Perani, D. (2020). Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum. Parkinsonism and Related Disorders, 81, 113-122. doi:10.1016/j.parkreldis.2020.10.036 Peer reviewed |
 | Sala, A., Caminiti, S. P., Iaccarino, L., Beretta, L., Iannaccone, S., Magnani, G., Padovani, A., Ferini-Strambi, L., & Perani, D. (2019). Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies. Human Brain Mapping, 40 (15), 4537-4550. doi:10.1002/hbm.24719 Peer Reviewed verified by ORBi |
 | Sala, A., Iaccarino, L., Fania, P., Vanoli, E. G., Fallanca, F., Pagnini, C., Cerami, C., Calvo, A., Canosa, A., Pagani, M., Chiò, A., Cistaro, A., & Perani, D. (2019). Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis. European Journal of Nuclear Medicine and Molecular Imaging, 46 (5), 1117-1131. doi:10.1007/s00259-018-4246-2 Peer Reviewed verified by ORBi |
 | Sala, A., Malpetti, M., Ferrulli, A., Gianolli, L., Luzi, L., & Perani, D. (2019). High body mass index, brain metabolism and connectivity: an unfavorable effect in elderly females. Aging, 11 (19), 8573-8586. doi:10.18632/aging.102347 Peer Reviewed verified by ORBi |
 | Santangelo, R., Dell'Edera, A., Sala, A., Cecchetti, G., Masserini, F., Caso, F., Pinto, P., Leocani, L., Falautano, M., Passerini, G., Martinelli, V., Comi, G., Perani, D., & Magnani, G. (2019). The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia. Current Alzheimer Research, 16 (7), 587-595. doi:10.2174/1567205016666190725150836 Peer Reviewed verified by ORBi |
 | Caminiti, S. P.* , Sala, A.* , Iaccarino, L.* , Beretta, L., Pilotto, A., Gianolli, L., Iannaccone, S., Magnani, G., Padovani, A., Ferini-Strambi, L., & Perani, D. (2019). Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimer's Research and Therapy, 11 (1), 20. doi:10.1186/s13195-019-0473-4 Peer reviewed* These authors have contributed equally to this work. |
 | Iaccarino, L., Sala, A., & Perani, D. (2019). Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Annals of Clinical and Translational Neurology, 6 (6), 1113-1120. doi:10.1002/acn3.782 Peer Reviewed verified by ORBi |
 | Sala, A., & Perani, D. (2019). Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography. Frontiers in Neuroscience, 13, 617. doi:10.3389/fnins.2019.00617 Peer Reviewed verified by ORBi |
 | Malpetti, M., Carli, G., Sala, A., Cerami, C., Marcone, A., Iannaccone, S., Magnani, G., & Perani, D. (2019). Variant-specific vulnerability in metabolic connectivity and resting-state networks in behavioural variant of frontotemporal dementia. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 120, 483-497. doi:10.1016/j.cortex.2019.07.018 Peer Reviewed verified by ORBi |
 | Malpetti, M., Sala, A., Vanoli, E. G., Gianolli, L., Luzi, L., & Perani, D. (2018). Unfavourable gender effect of high body mass index on brain metabolism and connectivity. Scientific Reports, 8 (1), 12584. doi:10.1038/s41598-018-30883-y Peer Reviewed verified by ORBi |
 | Caminiti, S. P., Ballarini, T., Sala, A., Cerami, C., Presotto, L., Santangelo, R., Fallanca, F., Vanoli, E. G., Gianolli, L., Iannaccone, S., Magnani, G., & Perani, D. (2018). FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. NeuroImage: Clinical, 18, 167-177. doi:10.1016/j.nicl.2018.01.019 Peer Reviewed verified by ORBi |
 | Presotto, L., Iaccarino, L., Sala, A., Vanoli, E. G., Muscio, C., Nigri, A., Bruzzone, M. G., Tagliavini, F., Gianolli, L., Perani, D., & Bettinardi, V. (2018). Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification. NeuroImage: Clinical, 20, 153-160. doi:10.1016/j.nicl.2018.07.013 Peer Reviewed verified by ORBi |
 | Iaccarino, L., Sala, A., Caminiti, S. P., Santangelo, R., Iannaccone, S., Magnani, G., & Perani, D. (2018). The brain metabolic signature of visual hallucinations in dementia with Lewy bodies. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 108, 13-24. doi:10.1016/j.cortex.2018.06.014 Peer Reviewed verified by ORBi |
 | Iaccarino, L., Sala, A., Caminiti, S. P., & Perani, D. (2017). The emerging role of PET imaging in dementia. F1000Research, 6, 1830. doi:10.12688/f1000research.11603.1 Peer Reviewed verified by ORBi |
 | Caminiti, S. P., Tettamanti, M., Sala, A., Presotto, L., Iannaccone, S., Cappa, S. F., Magnani, G., & Perani, D. (2017). Metabolic connectomics targeting brain pathology in dementia with Lewy bodies. Journal of Cerebral Blood Flow and Metabolism, 37 (4), 1311-1325. doi:10.1177/0271678X16654497 Peer reviewed |
 | Sala, A., Caminiti, S. P., Presotto, L., Premi, E., Pilotto, A., Turrone, R., Cosseddu, M., Alberici, A., Paghera, B., Borroni, B., Padovani, A., & Perani, D. (2017). Altered brain metabolic connectivity at multiscale level in early Parkinson's disease. Scientific Reports, 7 (1), 4256. doi:10.1038/s41598-017-04102-z Peer Reviewed verified by ORBi |
